cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25582/data.2025-01.3344516/2495914
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344533/2495915
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344582/2495916
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344588/2495917
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344596/2495918
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344611/2495919
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344637/2495920
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344653/2495921
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344658/2495922
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344667/2495923
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344678/2495924
title: Data for EMSL Project 60846 from January 2025
DOI: 10.25582/data.2025-01.3344707/2495925
title: Data for EMSL Project 60846 from January 2025
DOI: 10.5281/zenodo.13319808
title: Water Body Checklists 2019: Ceram Sea Species List

description: Species checklists created using effechecka and modified polygons from IHO. The polygons were reduced in resolution.List of species collected from the Ceram Sea using effechecka and a modified polygon from the International Hydrographic Association. A filter was applied (based on data from WoRMS) to remove all non-marine taxa.
DOI: 10.15468/dl.udfk7x
title: Occurrence Download

description: A dataset containing 4547 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Carcharhinus Blainville, 1816",
 "HasCoordinate is true",
 "Country is one of (Brazil, Colombia)"
 ]
}

 The dataset includes 4547 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057570-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.28139621
title: Datasets for forests-3392325

description: <b>Metadata Description</b>：<b>(1) Carbon sequestration supply (NEP)</b>The Carbon Sequestration Supply (NEP) data is produced based on the Carnegie-Ames-Stanford approach (CASA) model and Net Ecosystem Productivity (NEP) model, with a spatial resolution of 100 meters. The data content includes NEP datasets from Hainan Island, China in the years 2000, 2005, 2010, 2015 and 2020.<b>(2) Carbon sequestration demand (CSD)</b>The Carbon sequestration demand data is produced based on the emission factor assessment methods using energy consumption and population density, with a spatial resolution of 100 meters. The data content includes CSD datasets from Hainan Island, China in the years 2000, 2005, 2010, 2015 and 2020.<b>(3) Spatial linked characteristics based on gravitational force</b>To understand the degree of correlation and the extent of spatial correlation between the region's carbon sequestration supply and demand, we introduce the concept of regional supply and demand gravity. A higher gravitational force between two locations indicates that the transport corridor connecting them facilitates a greater flow of sequestered carbon streams, signifying its heightened importance.
DOI: 10.6084/m9.figshare.28139621.v1
title: Datasets for forests-3392325

description: <b>Metadata Description</b>：<b>(1) Carbon sequestration supply (NEP)</b>The Carbon Sequestration Supply (NEP) data is produced based on the Carnegie-Ames-Stanford approach (CASA) model and Net Ecosystem Productivity (NEP) model, with a spatial resolution of 100 meters. The data content includes NEP datasets from Hainan Island, China in the years 2000, 2005, 2010, 2015 and 2020.<b>(2) Carbon sequestration demand (CSD)</b>The Carbon sequestration demand data is produced based on the emission factor assessment methods using energy consumption and population density, with a spatial resolution of 100 meters. The data content includes CSD datasets from Hainan Island, China in the years 2000, 2005, 2010, 2015 and 2020.<b>(3) Spatial linked characteristics based on gravitational force</b>To understand the degree of correlation and the extent of spatial correlation between the region's carbon sequestration supply and demand, we introduce the concept of regional supply and demand gravity. A higher gravitational force between two locations indicates that the transport corridor connecting them facilitates a greater flow of sequestered carbon streams, signifying its heightened importance.
DOI: 10.15468/dl.hqe6ez
title: Occurrence Download

description: A dataset containing 567 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-100.375 21.304,-100.318 21.304,-100.318 21.357,-100.375 21.357,-100.375 21.304))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 567 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057571-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qwk4p6
title: Occurrence Download

description: A dataset containing 4547 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Carcharhinus Blainville, 1816",
 "HasCoordinate is true",
 "Country is one of (Brazil, Colombia)"
 ]
}

 The dataset includes 4547 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057572-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.28139810
title: Supplementary Material for: Rarity of congenital adrenal hyperplasia in children born very preterm:Possible mechanism and implication for newborn screening

description: Introduction:Screening for congenital adrenal hyperplasia through the measurement of 17-hydroxyprogesterone on the neonatal blood spot aims to: a) prevent neonatal deaths; b) allow earlier identification and thereby decrease the severity of the initial salt-wasting episode; and c) shorten the time during which a severely virilized genetic female newborn may be assigned the male sex. It is now practiced in the majority of high-income countries, although the positive predictive value of the test is very low in infants born preterm, who seem to be infrequently affected. In almost all low- and middle-income countries, it has not yet been implemented. 
Methods:To determine if it is justified in such a country, we evaluated the prevalence of premature birth and the sex ratio in a cohort of 299 singleton Algerian infants diagnosed with congenital adrenal hyperplasia. 
Results: Only 4% were born before 37 weeks of gestational age, less than the 14.3% observed in the general Algerian population. None was born before 34 weeks of gestation. The salt-wasting form of the disease was confirmed in 93 boys and 139 girls. 
Conclusion: We speculate that the combination of a high production of 17-hydroxyprogesterone with a low production of cortisol by the fetus with congenital adrenal hyperplasia accounts for the rarity of very preterm birth in this population. We suggest that newborn screening for congenital adrenal hyperplasia is necessary in Algeria to equalize the sex ratio but that it could be restricted to neonates born after 32 weeks of gestation, thereby possibly improving the cost-effectiveness ratio of this intervention.
DOI: 10.15468/dl.ku6zgp
title: Occurrence Download

description: A dataset containing 4547 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Carcharhinus Blainville, 1816",
 "HasCoordinate is true",
 "Country is one of (Brazil, Colombia)"
 ]
}

 The dataset includes 4547 records from 65 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057573-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14602956
title: Global Bionic Devices Market 2024 To 2033

description: Bionic Devices Market Size, Trends and Insights By Fixation (Implantable, Wearable/ Externally Worn), By Product (Auditory Bionics/Cochlear Implants, Heart Transplant, Orthopedic Bionics, Neural Bionics), By Technology (Electronic, Mechanical), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Healthcare Facilities), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Bionic Devices Market is expected to record a CAGR of 8.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 5.54 Billion. By 2033, the valuation is anticipated to reach USD 11.23 Billion.

The bionic devices market encompasses the development, production, and sale of advanced prosthetic and assistive devices that integrate electronic and mechanical components to replicate or enhance human biological functions. These devices are designed to restore or improve mobility, sensory perception, and other bodily functions for individuals with disabilities or medical conditions.

Bionic devices include prosthetic limbs, robotic exoskeletons, bionic eyes, and other wearable technologies that combine bioengineering, robotics, and artificial intelligence to provide enhanced functionality and user experience. The market serves the healthcare, rehabilitation, and personal mobility sectors, addressing the needs of patients, clinicians, and caregivers.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=52923
DOI: 10.5281/zenodo.14602957
title: Global Bionic Devices Market 2024 To 2033

description: Bionic Devices Market Size, Trends and Insights By Fixation (Implantable, Wearable/ Externally Worn), By Product (Auditory Bionics/Cochlear Implants, Heart Transplant, Orthopedic Bionics, Neural Bionics), By Technology (Electronic, Mechanical), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Healthcare Facilities), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Bionic Devices Market is expected to record a CAGR of 8.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 5.54 Billion. By 2033, the valuation is anticipated to reach USD 11.23 Billion.

The bionic devices market encompasses the development, production, and sale of advanced prosthetic and assistive devices that integrate electronic and mechanical components to replicate or enhance human biological functions. These devices are designed to restore or improve mobility, sensory perception, and other bodily functions for individuals with disabilities or medical conditions.

Bionic devices include prosthetic limbs, robotic exoskeletons, bionic eyes, and other wearable technologies that combine bioengineering, robotics, and artificial intelligence to provide enhanced functionality and user experience. The market serves the healthcare, rehabilitation, and personal mobility sectors, addressing the needs of patients, clinicians, and caregivers.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=52923
DOI: 10.15468/dl.4mfcuy
title: Occurrence Download

description: A dataset containing 1683 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Country is Canada",
 "TaxonKey is Amanita muscaria (L.) Lam.",
 "DecimalLongitude is -79.3439314990000071,-63.9999979090000011",
 "DecimalLatitude is 45.0000682390000009, 50.0000022050000013"
 ]
}

 The dataset includes 1683 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057574-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.28139819
title: Supplementary Material for: Region of Birth Differences in Medication Adherence Among Patients with Stroke or Transient Ischemic Attack

description: Background and Purpose: Cultural and language barriers may affect quality of care, such as adherence to medications. We examined whether adherence to prevention medications within the year after stroke/transient ischemic attack (TIA) differed by region of birth.
Methods: An observational study of adults with stroke/TIA admitted to hospitals in the Australian Stroke Clinical Registry (Queensland, Victoria; 2012-2016; n=45 hospitals), with linked administrative data. Region of birth was categorized into 10 groups (Australia, Other Oceania, North-West Europe, Southern/Eastern Europe, North Africa/Middle East, South-East Asia, North-East Asia, Southern/Central Asia, Americas, Sub-Saharan Africa). Analysis was limited to those with a first-ever stroke/TIA who were dispensed an antihypertensive, lipid-lowering, or antithrombotic medication within 1-year post-discharge. Medication adherence was calculated based on the proportion of days covered until 1 year immediately post-discharge/death. Associations between region of birth and being adherent (PDC ≥80%) was determined using multivariable logistic regression (adjusted for age, sex, stroke type, ability to walk on admission, discharge destination, socioeconomic position, main language spoken, comorbidity score). 
Results: Among 24,236 eligible participants (median age 74 years, 44% female, 68% Australian-born), 54% were adherent to antihypertensive medications, 56% to lipid-lowering medications, and 49% to antithrombotic medications. Compared to Australian-born participants, those born in Other Oceania (4.0%) were less likely to be adherent to lipid-lowering medications (OR 0.78, 95% CI 0.67-0.90) and antithrombotic (OR 0.84, 95% CI 0.72-0.97). Compared to Australian-born participants, those born in Southern and Central Asia (1.4%) were less likely to be adherent to lipid-lowering medications (odds ratio [OR]: 0.76, 95% CI 0.58-0.99) and antithrombotic (0.55, 95% CI 0.40-0.76). No significant differences were found with other regions.
Conclusions: Disparities by the region of birth were observed in medication adherence after stroke/TIA for participants born in Asia and Oceania. Targeted education to improve medication adherence, specific to the needs of these groups, is warranted.
DOI: 10.6084/m9.figshare.28139819.v1
title: Supplementary Material for: Region of Birth Differences in Medication Adherence Among Patients with Stroke or Transient Ischemic Attack

description: Background and Purpose: Cultural and language barriers may affect quality of care, such as adherence to medications. We examined whether adherence to prevention medications within the year after stroke/transient ischemic attack (TIA) differed by region of birth.
Methods: An observational study of adults with stroke/TIA admitted to hospitals in the Australian Stroke Clinical Registry (Queensland, Victoria; 2012-2016; n=45 hospitals), with linked administrative data. Region of birth was categorized into 10 groups (Australia, Other Oceania, North-West Europe, Southern/Eastern Europe, North Africa/Middle East, South-East Asia, North-East Asia, Southern/Central Asia, Americas, Sub-Saharan Africa). Analysis was limited to those with a first-ever stroke/TIA who were dispensed an antihypertensive, lipid-lowering, or antithrombotic medication within 1-year post-discharge. Medication adherence was calculated based on the proportion of days covered until 1 year immediately post-discharge/death. Associations between region of birth and being adherent (PDC ≥80%) was determined using multivariable logistic regression (adjusted for age, sex, stroke type, ability to walk on admission, discharge destination, socioeconomic position, main language spoken, comorbidity score). 
Results: Among 24,236 eligible participants (median age 74 years, 44% female, 68% Australian-born), 54% were adherent to antihypertensive medications, 56% to lipid-lowering medications, and 49% to antithrombotic medications. Compared to Australian-born participants, those born in Other Oceania (4.0%) were less likely to be adherent to lipid-lowering medications (OR 0.78, 95% CI 0.67-0.90) and antithrombotic (OR 0.84, 95% CI 0.72-0.97). Compared to Australian-born participants, those born in Southern and Central Asia (1.4%) were less likely to be adherent to lipid-lowering medications (odds ratio [OR]: 0.76, 95% CI 0.58-0.99) and antithrombotic (0.55, 95% CI 0.40-0.76). No significant differences were found with other regions.
Conclusions: Disparities by the region of birth were observed in medication adherence after stroke/TIA for participants born in Asia and Oceania. Targeted education to improve medication adherence, specific to the needs of these groups, is warranted.
DOI: 10.5281/zenodo.14602908
title: Chen & Gung, 2025-Monthly stacked CCFs

description: Chen & Gung, 2025

Monthly stacked cross-correlation functions calculated from continuous ocean-bottom pressure data of OBS arrays in the Pacific Ocean

tar -xzvf Chen_Gung_2025_JGR-ocean_monthly_stacked_CCFs.tar to uncompress the files
DOI: 10.5281/zenodo.14602909
title: Chen & Gung, 2025-Monthly stacked CCFs

description: Chen & Gung, 2025

Monthly stacked cross-correlation functions calculated from continuous ocean-bottom pressure data of OBS arrays in the Pacific Ocean

tar -xzvf Chen_Gung_2025_JGR-ocean_monthly_stacked_CCFs.tar to uncompress the files
DOI: 10.5281/zenodo.14602966
title: Global Milk Thistle Sprouts Market 2024 To 2033

description: Milk Thistle Sprouts Market Size, Trends and Insights By Type (Organic, Conventional), By Application (Pharmaceuticals, Nutraceuticals, Cosmetics, Others), By Distribution Channels (Retail Stores, Supermarket & Hypermarkets, Pharmacies, Online, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Milk Thistle Sprouts Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 344.3 Million. By 2033, the valuation is anticipated to reach USD 638.4 Million.

The milk thistle sprouts market encompasses the production, distribution, and consumption of sprouted seeds from the milk thistle plant, known for its potential health benefits. These sprouts are rich in antioxidants, vitamins, and minerals, offering liver support, detoxification, and anti-inflammatory properties. The market caters to various industries, including pharmaceuticals, nutraceuticals, and functional foods.

Key players range from agricultural producers to pharmaceutical companies, offering various products such as sprouted seeds, supplements, extracts, and skincare formulations. Growing consumer awareness of natural health remedies and increasing demand for plant-based products drive market expansion and innovation.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=53204
DOI: 10.5281/zenodo.14602967
title: Global Milk Thistle Sprouts Market 2024 To 2033

description: Milk Thistle Sprouts Market Size, Trends and Insights By Type (Organic, Conventional), By Application (Pharmaceuticals, Nutraceuticals, Cosmetics, Others), By Distribution Channels (Retail Stores, Supermarket & Hypermarkets, Pharmacies, Online, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the global Milk Thistle Sprouts Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 344.3 Million. By 2033, the valuation is anticipated to reach USD 638.4 Million.

The milk thistle sprouts market encompasses the production, distribution, and consumption of sprouted seeds from the milk thistle plant, known for its potential health benefits. These sprouts are rich in antioxidants, vitamins, and minerals, offering liver support, detoxification, and anti-inflammatory properties. The market caters to various industries, including pharmaceuticals, nutraceuticals, and functional foods.

Key players range from agricultural producers to pharmaceutical companies, offering various products such as sprouted seeds, supplements, extracts, and skincare formulations. Growing consumer awareness of natural health remedies and increasing demand for plant-based products drive market expansion and innovation.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=53204
DOI: 10.5281/zenodo.14383454
title: Dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

description: Including dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

(1) 5_class dataset for train_val and test (calculated tsfresh features)

(2) 6_class dataset for train_val and test (calculated tsfresh features)

(3) ode_raw_data obtained by solving rxn kinetic ode, which can be used to generate dataset (1) and (2).
DOI: 10.5281/zenodo.14578153
title: Dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

description: Including dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

(1) 5_class dataset for train_val and test (calculated tsfresh features)

(2) 6_class dataset for train_val and test (calculated tsfresh features)

(3) ode_raw_data obtained by solving rxn kinetic ode, which can be used to generate dataset (1) and (2).
DOI: 10.5281/zenodo.14583313
title: Dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

description: Including dataset for Classification_of_Substrate_Orders_in_Reaction_Kinetics

(1) 5_class dataset for train_val and test (calculated tsfresh features)

(2) 6_class dataset for train_val and test (calculated tsfresh features)

(3) ode_raw_data obtained by solving rxn kinetic ode, which can be used to generate dataset (1) and (2).

 

The codes and more information could be found in Github repo: https://github.com/tom832/Classification_of_Substrate_Orders_in_Reaction_Kinetics.git
DOI: 10.15468/dl.4kdmaz
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "DatasetKey is Museum of Comparative Zoology, Harvard University",
 "TaxonKey is Columba livia J.F.Gmelin, 1789",
 "Year 1986-1988"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057577-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fc47m3
title: Occurrence Download

description: A dataset containing 827863 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Carcharhinus Blainville, 1816",
 "HasCoordinate is true"
 ]
}

 The dataset includes 827863 records from 410 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0057575-241126133413365/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3535/g5q-9zk-v4l
title: Notodonta ziczac (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/za1-ebj-30g
title: Trichiura crataegi (Linnaeus, 1758)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.